12 Best Low Risk High Growth Stocks to Invest In

Page 2 of 12

11. Lantheus Holdings, Inc. (NASDAQ:LNTH)

Number of Hedge Fund Holders: 35     

Lantheus Holdings, Inc. (NASDAQ:LNTH) is a radiopharmaceutical company that specializes in the development and distribution of precision diagnostic and therapeutic products. The firm’s third-quarter earnings signal strong business expansion, driven by higher demand and increased market share, with worldwide revenue reaching $378.7 million, an 18.4% increase from the previous year. On January 28, the company announced a definitive agreement to acquire Evergreen Theragnostics in an all-cash deal, which includes an upfront payment of $250 million and up to $752.5 million in potential milestone payments. Brian Markison, CEO of Lantheus, said on this occasion that this acquisition would expand the oncology radiopharmaceutical pipeline with multiple clinical and pre-clinical theranostic pairs.

Page 2 of 12